Accolade, Inc. announced that it will release its fiscal third quarter 2025 financial results on January 9, 2024, after market close, and will host a conference call at 4:30 p.m. ET that same day.

Accolade Announces Results for Fiscal Second Quarter 2024 Accolade options imply 10.8% move in share price post-earnings Options Volatility and Implied Earnings Moves Today, October 04, 2023 ...

Accolade, Inc. (NASDAQ:ACCD) insiders who purchased shares in the last 12 months were richly rewarded last week. The stock climbed by 9.4% resulting in a US$76m addition to the company’s market ...

Shares of Accolade Inc. lost half their value Friday, after the personalized virtual health care services company reported a wider-than-expected fiscal fourth-quarter loss, and said it would lose ...

NEW YORK, NY / ACCESSWIRE / August 8, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Accolade, Inc. ("Accolade") (NASDAQ:ACCD) concerning possible violations ...

Accolade, Inc. (ACCD) Q4 2023 Earnings Conference Call April 27, 2023 4:30 PM ETCompany ParticipantsTodd Friedman - Head of Investor RelationsRajeev Singh - ...

Accolade, Inc. (NASDAQ: ACCD) shares are trading lower after-hours on Wednesday after the company announced results for the second-quarter 2024 ...

Accolade Inc ACCD posted Q1 FY24 sales of $93.2 million, up 9% Y/Y, beating the consensus of $90.30 million. The company posted an EPS loss of $(0.52), ahead of the consensus of $(0.62) and much ...

Accolade Inc. has agreed to acquire telemedicine company 2nd.MD in a deal valued at up to $460 million, six months after an initial public offering.

Accolade Inc. said late Thursday it has agreed to buy Innovation Specialists LLC, which does business as 2nd.MD, a "leading" expert medical opinion and medical decision support company based in ...

Accolade, Inc. (ACCD) Q2 2023 Earnings Conference Call October 6, 2022 4:30 PM ETCompany ParticipantsRajeev Singh - Chief Executive OfficerSteve Barnes - ...